Dexcom (NSDQ:DXCM) raised its full-year outlook yesterday after the medical device maker topped expectations on Wall Street with its third-quarter financial results.
The San Diego, Calif.-based company posted profits of $46.6 million, or 53¢ per share, on sales of $266.7 million for the 3 months ended Sept. 30, for sales growth of 44% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Dexcom raises outlook after Q3 results top Wall Street estimates appeared first on MassDevice.
from MassDevice https://ift.tt/2F84keh
Cap comentari:
Publica un comentari a l'entrada